Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Altucci

Showing results (291-300 of 358) with videos related to

Pageof 36
Sort By:
Biology Open|October 30, 2013
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cellsGianluigi Franci, Laura Casalino, Francesca Petraglia, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 6, 2025
Correction: MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interactionMarco Bocchetti, Alessia Maria Cossu, Manuela Porru, et al.
European Journal of Pharmacology|October 29, 2022
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosisMargherita Brindisi, Simona Barone, Alice Rossi, et al.
Journal of Cellular Biochemistry|March 4, 2006
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cellsClaudio Scafoglio, Concetta Ambrosino, Luigi Cicatiello, et al.
Journal of Medicinal Chemistry|July 23, 2025
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate CancerAndrea Citarella, Silvia Belluti, Davide Bonanni, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cellsElisabetta Di Bello, Veronica Sian, Giulio Bontempi, et al.
Clinical Epigenetics|March 31, 2021
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedsideFederica Sarno, Giuditta Benincasa, Markus List, et al.
Signal Transduction and Targeted Therapy|January 19, 2026
Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinomaUgo Chianese, Chiara Papulino, Gerardo Saggese, et al.
Cancers|March 28, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. <i>Cancers</i> 2020, <i>12</i>, 447Clemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Pageof 36

Showing results (291-300 of 358) with videos related to

Sort By:
Pageof 36
Biology Open|October 30, 2013
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cellsGianluigi Franci, Laura Casalino, Francesca Petraglia, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 6, 2025
Correction: MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interactionMarco Bocchetti, Alessia Maria Cossu, Manuela Porru, et al.
European Journal of Pharmacology|October 29, 2022
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosisMargherita Brindisi, Simona Barone, Alice Rossi, et al.
Journal of Cellular Biochemistry|March 4, 2006
Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cellsClaudio Scafoglio, Concetta Ambrosino, Luigi Cicatiello, et al.
Journal of Medicinal Chemistry|July 23, 2025
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate CancerAndrea Citarella, Silvia Belluti, Davide Bonanni, et al.
European Journal of Medicinal Chemistry|December 22, 2022
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cellsElisabetta Di Bello, Veronica Sian, Giulio Bontempi, et al.
Clinical Epigenetics|March 31, 2021
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedsideFederica Sarno, Giuditta Benincasa, Markus List, et al.
Signal Transduction and Targeted Therapy|January 19, 2026
Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinomaUgo Chianese, Chiara Papulino, Gerardo Saggese, et al.
Cancers|March 28, 2024
Correction: Zwergel et al. Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation. <i>Cancers</i> 2020, <i>12</i>, 447Clemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Pageof 36